Summary of findings for the main comparison. Comparison of plasma transfusions versus no plasma transfusions when the INR is 1.5 prior to central venous catheter insertion.
Comparison of plasma transfusions versus no plasma transfusions | ||||||
Patient or population: people with abnormal coagulation requiring a central venous catheter Setting: In hospital Intervention: prophylactic plasma transfusion Comparison: no plasma transfusions | ||||||
Outcomes | Anticipated absolute effects* (95% CI) | Relative effect (95% CI) | № of participants (studies) | Quality of the evidence (GRADE) | Comments | |
Risk with no plasma transfusions | Risk with prophylactic plasma transfusion | |||||
Major procedure‐related bleeding follow‐up: 24 hours | There were no major procedure‐related bleeds in either of the study arms | Not estimable |
58 (1 RCT) |
⊕⊝⊝⊝ VERY LOW 1 2 | ||
All‐cause mortality follow‐up: 30 days | ‐ | ‐ | ‐ | ‐ | Not reported |
|
Respiratory deterioration attributable to transfusion‐associated circulatory overload (TACO), transfusion‐related acute lung injury (TRALI) or transfusion‐associated dyspnoea (TAD) | ‐ | ‐ | ‐ | ‐ | ‐ | Not reported |
Minor procedure‐related bleeding follow‐up: 24 hours | Study population | RR 0.67 (0.12 to 3.70) | 58 (1 RCT) | ⊕⊝⊝⊝ VERY LOW 2 3 | ||
103 per 1000 | 69 per 1000 (12 to 383) | |||||
Proportion of participants receiving plasma transfusions | ‐ | ‐ | ‐ | ‐ | ‐ | Not reported |
Line‐related complications | ‐ | ‐ | ‐ | ‐ | ‐ | Not reported |
Quality of life | ‐ | ‐ | ‐ | ‐ | ‐ | Not reported |
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). CI: Confidence interval; RR: Risk ratio | ||||||
GRADE Working Group grades of evidence High quality: We are very confident that the true effect lies close to that of the estimate of the effect Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect |
1 Downgraded by 2 for very serious imprecision. The included study was a small study and this is a rare outcome with no events in either study arm
2 Downgraded by 1 for serious risk of bias. There was a high risk of performance bias and other bias
3 Downgraded by 2 for very serious imprecision. The included study was a small study and the 95% confidence interval of the risk ratio includes the possibility of significant harm or significant benefit.